Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Elevance Health Inc.
Bear Case (25th pct.)
-43.4% vs price
Base Case (Median)
-35.6% vs price
Bull Case (75th pct.)
1.5% vs price
◇ = Current price | | Bear | Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $156.18 | -67.6% | High (40%) |
| PE Comparable | $535.07 | 10.9% | Medium (25%) |
| Growth Trajectory DCF | $622.20 | 28.9% | Medium (20%) |
| Graham Number | $310.74 | -35.6% | Medium (40%) |
| EV/EBITDA | $304.84 | -36.8% | Medium (20%) |
| EV/FCF | $444.81 | -7.8% | Medium (20%) |
| Earnings Power Value | $241.91 | -49.9% | Medium (50%) |
Based on 7 out of 7 methods, ANTM appears fairly valued at the current price of $482.58. The base case fair value of $310.74 implies 35.6% downside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.